Currently out of the existing stock ratings of Emily Bodnar, 332 are a BUY (88.53%), 43 are a HOLD (11.47%).

Emily Bodnar

Work Performance Price Targets & Ratings Chart

Analyst Emily Bodnar, carries an average stock price target met ratio of 35.5% that have a potential upside of 57.91% achieved within 128 days.

Emily Bodnar’s has documented 668 price targets and ratings displayed on 33 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on TGTX, TG Therapeutics at 06-Jul-2026.

Wall Street Analyst Emily Bodnar

Analyst best performing recommendations are on SQZ (SQZ BIOTECHNOLOGIES CO).
The best stock recommendation documented was for OLMA (OLEMA PHARMACEUTICALS) at 10/20/2025. The price target of $28 was fulfilled within 37 days with a profit of $20.23 (260.36%) receiving and performance score of 70.37.

Average potential price target upside

DICE Dice Molecules Holdings LLC FEMY Femasys NVCR Novocure Ltd OLMA Olema Pharmaceuticals VTYX Ventyx Biosciences SQZ Sqz Biotechnologies Co ACLX Arcellx BCTX Briacell Therapeutics Corp CNTX Context Therapeutics GRCL Gracell Biotechnologies INKT Mink Therapeutics IOBT IO Biotech NKTX Nkarta  RNAZ Transcode Therapeutics AGEN Agenus SANA Sana Biotechnology JSPR Jasper Therapeutics ANAB AnaptysBio RCUS Arcus Biosciences GERN Geron NXTC NextCure  ATOS Atossa Genetics CNTB Connect Biopharma Holdings Ltd ACRV Acrivon Therapeutics, Common Stock GNLX Genelux Common Stock PPBT Purple Biotech SLRN ACELYRIN, INC. Common Stock AGIO Agios Pharm RAPT RAPT Therapeutics VTVT vTv Therapeutics ARTV Artiva Biotherapeutics, Common Stock SABS SAB Biotherapeutics TGTX TG Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Aug-2023

$48

$0.45 (0.95%)

$48

2 years 11 months 5 days ago
(09-Aug-2023)

1/8 (12.5%)

$0.45 (0.95%)

85

Hold Since 26-Jun-2023

$56

3 years 18 days ago
(26-Jun-2023)

0/1 (0%)

$27.35 (95.46%)

Buy Since 22-May-2023

$48

3 years 23 days ago
(21-Jun-2023)

0/2 (0%)

$1.56 (3.36%)

Buy Since 14-Sep-2022

$48

$0.45 (0.95%)

$68

3 years 24 days ago
(20-Jun-2023)

1/3 (33.33%)

$1.56 (3.36%)

27

Hold Since 24-May-2023

$48

$0.45 (0.95%)

$38

3 years 24 days ago
(20-Jun-2023)

1/2 (50%)

$1.56 (3.36%)

27

Show more analysts

Please expand the browser size to see the chart

Which stock is Emily Bodnar is most bullish on?

Potential upside of $29.7 has been obtained for NVCR (NOVOCURE LTD)

Which stock is Emily Bodnar is most reserved on?

Potential downside of -$0.39 has been obtained for ANAB (ANAPTYSBIO)

What Year was the first public recommendation made by Emily Bodnar?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?